Sucampo Pharma (SCMP) Tops Q4 EPS by 24c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts SCMP Hot Sheet
Price: $18.00 --0%
Financial Fact:
Income tax benefit (provision): -7.41M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Income tax benefit (provision): -7.41M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Sucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.43, $0.24 better than the analyst estimate of $0.19. Revenue for the quarter came in at $55.4 million versus the consensus estimate of $42.72 million.
For earnings history and earnings-related data on Sucampo Pharma (SCMP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Becton Dickinson (BDX) Tops Q4 EPS by 8c; Offers Guidance
- Kelly Services (KELYA) Misses Q3 EPS by 5c
- Parker-Hannifin (PH) Tops Q1 EPS by 69c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
